CIB2 Gene Deafness Autosomal Recessive Type 48 Genetic Test
Welcome to DNA Labs UAE, where we offer the CIB2 Gene Deafness Autosomal Recessive Type 48 Genetic Test. This test is designed to identify mutations in the CIB2 gene that may be responsible for this specific type of genetic deafness. Read on to learn more about the test, its cost, symptoms, diagnosis, and more.
Test Details
CIB2 gene deafness, autosomal recessive type 48 is a specific type of genetic deafness that is caused by mutations in the CIB2 gene. This condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene (one from each parent) to develop the disorder.
Test Components and Price
The CIB2 Gene Deafness Autosomal Recessive Type 48 Genetic Test is priced at 4400.0 AED. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA Card.
Report Delivery
The report for the CIB2 Gene Deafness Autosomal Recessive Type 48 Genetic Test will be delivered within 3 to 4 weeks.
Method
The test utilizes NGS (Next-Generation Sequencing) technology, which allows for the analysis of multiple genes simultaneously.
Test Type
The CIB2 Gene Deafness Autosomal Recessive Type 48 Genetic Test falls under the category of Ear Nose Throat Disorders.
Doctor and Test Department
The test is performed by an ENT Doctor in the Genetics department.
Pre Test Information
Prior to the test, it is important to provide the clinical history of the patient who is going for the IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test. A Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with the IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS10.
Benefits of Genetic Testing
NGS genetic testing for CIB2 gene deafness, autosomal recessive type 48 can provide valuable information for diagnosis, prognosis, and potential treatment options. It can also be used for carrier screening, allowing individuals to determine if they carry a mutation in the CIB2 gene and may potentially pass it on to their children.
Guidance and Support
It’s important to note that genetic testing should always be conducted under the guidance of a healthcare professional or genetic counselor who can provide appropriate counseling and support.
| Test Name | CIB2 Gene Deafness autosomal recessive type 48 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Ear Nose Throat Disorders |
| Doctor | ENT Doctor |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS10 |
| Test Details | CIB2 gene deafness, autosomal recessive type 48 is a specific type of genetic deafness that is caused by mutations in the CIB2 gene. This condition is inherited in an autosomal recessive manner, which means that an individual must inherit two copies of the mutated gene (one from each parent) in order to develop the disorder. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of CIB2 gene deafness, autosomal recessive type 48, NGS genetic testing can be used to identify mutations in the CIB2 gene that may be responsible for the condition. By identifying these mutations, NGS genetic testing can provide valuable information for diagnosis, prognosis, and potential treatment options for individuals with CIB2 gene deafness, autosomal recessive type 48. This type of genetic testing can also be used for carrier screening, allowing individuals to determine if they carry a mutation in the CIB2 gene and may potentially pass it on to their children. It’s important to note that genetic testing should always be conducted under the guidance of a healthcare professional or genetic counselor who can provide appropriate counseling and support. |
